Frequently Asked Questions

Who Must Obtain DEA Registration?

Healthcare Professionals Handling Controlled Substances

DEA registration is required for practitioners who prescribe, dispense, administer, or procure controlled substances (Schedules II-V). This applies to physicians, dentists, nurse practitioners, physician assistants, optometrists, podiatrists, veterinarians, and pharmacists. Trainees and residents may operate under an institutional DEA registration.

Veterinary Practices & Relief Vets

Veterinarians must register individually if they dispense or administer controlled substances. A single DEA registration for a practice does not cover associate or relief veterinarians. Mobile veterinarians are covered under the Veterinary Medicine Mobility Act if transporting up to a seven-day supply. Relief vets must register their home address for DEA purposes unless working under a clinic's registration.

State Licensing Prerequisites

Practitioners must hold an active state medical license and comply with state-controlled substance laws before applying. Military personnel may qualify for a 180-day grace period for license transfers and dual-state DEA registration during Permanent Change of Station (PCS) moves.

Key Application Steps

State Compliance

Practitioners must first secure a state medical license and, if required, a controlled substance permit before applying for a DEA registration.

DEA Form Submission

New applicants must submit Form 224, while renewals require Form 224a. Telemedicine practitioners must submit Form 224S for special registration and notify the DEA of platform or practice changes within 14 days using Form 224S-M.

Common Compliance Pitfalls

Failure to renew registration results in a loss of prescribing privileges. Inaccurate record-keeping, security lapses, and state license issues can lead to enforcement actions. Multi-state practitioners must obtain separate DEA registrations where controlled substances are stored or administered. Common denial reasons include disciplinary actions, payment issues, and address mismatches between NPI, state, and DEA records.

Legal Risks & Defense Strategies

Denial or Revocation Grounds

A DEA registration may be denied or revoked due to felony convictions related to controlled substances, falsified applications, or exclusion from Medicare/Medicaid programs.

Voluntary Surrender Risks

Surrendering a DEA registration is irreversible and may trigger state licensing board investigations or employment termination.

How Can Health Law Alliance Assist

Legal support includes guidance on applications, appeals, and hearings for denials or revocations. We can assist with audit preparedness, record-keeping compliance, and crisis management in DEA investigations. Assistance with SCRA compliance and telemedicine registration is also available.

MORE ARTICLES BY CATEGORY

Get a Free Case REVIEW

100% Confidential & Secure. Your details are safe with us.

We'll speak soon!

In the meantime, why not find out more about us or visit our blog.

Alternatively, give us a call at (800) 345 - 4125

Oops! Something went wrong while submitting the form.

Guidance for New Entrants on Navigating PBM Audit Complexities

New pharmacy owners face complex PBM audit requirements that demand strict documentation, accurate claims, and ongoing compliance. Establishing strong recordkeeping systems and proactive audit readiness can help prevent costly recoupments and protect long-term network participation.

Read More >>

How Pharmacies Can Challenge Unfair PBM Audit Findings

PBM audits can leave pharmacies facing exaggerated findings, steep recoupments, and even network termination. With the right strategies and legal support, pharmacies can successfully challenge unfair results and protect their business.

Read More >>

Top Red Flags That May Trigger a PBM Audit

PBM audits can be disruptive, costly, and often triggered by high prescription volumes, dispensing irregularities, or claim activity. Pharmacies can reduce risks through strong documentation, compliance, and legal support to challenge unfair findings and protect network status.

Read More >>

Approaching the Telehealth Policy Cliff: Medicare Telehealth Flexibilities to Expire Next Week

Without further congressional action, COVID-19 era telehealth flexibilities are set to expire on September 30, 2025. Read more to learn about what’s set to change and key guidance for telehealth providers to prepare to adapt to pre-pandemic coverage rules.

Read More >>